title: Management of diabetic cats with long-acting insulin.
abstract: This article provides an overview of the most important information regarding the long-acting insulins glargine, detemir, and protamine zinc insulin in diabetic cats. Dosing protocols are described in detail, which achieve high remission rates and optimal glycemic control. Complications and factors that typically cause insulin resistance are also examined.
authors.affiliation: Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Belval 4362, Luxembourg.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Roomp
authors.forename: Jacquie S
authors.initials: JS
authors.lastname: Rand
mesh_terms: D000818:Animals; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000662:veterinary*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced / Q000517:prevention & control / Q000662:veterinary; D004305:Dose-Response Relationship, Drug; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control / Q000662:veterinary; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007333:Insulin Resistance; D049528:Insulin, Long-Acting / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting